Crossmark

Genome-wide DNA methylation profiling of triple-negative breast cancer uncovers epigenetic biomarkers of tumor identity and the immune microenvironment

Crossref DOI link: https://doi.org/10.1038/s41523-026-01030-y

Published Online: 2026-08-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sasiain, Iñaki

Nacer, Deborah F.

Jönsson, Mats

Vallon-Christersson, Johan

Grigoriadis, Anita

Aine, Mattias

Staaf, Johan
Funding

Funding for this research was provided by:

Breast Cancer Now (147; KCL-BCN-Q3)

MRC (MR/X012476/1)

CRUK City of London Centre (CANCTA-2022/100001)

Cancerfonden (CAN 2021/1407 JS, 2024/3591 JS)

Fru Berta Kamprads Stiftelse (FBKS-2020-5 JS and FBKS-2024-14 JS)

Vetenskapsrådet (2021-01800, 2025-02643)

BCF-VÖS Foundation

the National Society of Breast Cancer Associations in Sweden

Swedish governmental funding (2022/0021)
License Information

Text and Data Mining valid from 2026-08-12

Version of Record valid from 2026-08-12
More Information

Article History

Received: 10 April 2026

Accepted: 1 August 2026

First Online: 12 August 2026

Ethics

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below